{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:17:31Z","timestamp":1791811051135,"version":"4.3.4"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Idiopathic intracranial hypertension (IIH) primarrily affects obese women of childbearing years and is commonly associated with headaches, pulsatile tinnitus, and vision changes. Though most patients have a \u201cbenign\u201d course, it can lead to significant morbidity, including blindness. The treatment approach is based on severity of visual impact and includes weight loss, intracranial pressure lowering medications, and sometimes surgery, such as spinal fluid diversion, optic nerve sheath fenestration, or venous sinus stenting. More studies are needed to determine when surgery is most appropriate and which surgical procedure provides maximal benefit with the least risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aian.aian_203_22","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T02:29:43Z","timestamp":1654741783000},"page":"S59-S64","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Idiopathic Intracranial Hypertension from Benign to Fulminant"],"prefix":"10.4103","volume":"25","author":[{"given":"Meagan D.","family":"Seay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen B.","family":"Digre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20240828","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1212\/WNL.0000000000001687","article-title":"Quality of life in idiopathic intracranial hypertension at diagnosis","volume":"84","author":"Digre","year":"2015","journal-title":"Neurology"},{"key":"R2-4-20240828","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1212\/01.WNL.0000029570.69134.1B","article-title":"Diagnostic criteria for idiopathic intracranial hypertension","volume":"59","author":"Friedman","year":"2002","journal-title":"Neurology"},{"key":"R3-4-20240828","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","article-title":"Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children","volume":"81","author":"Friedman","year":"2013","journal-title":"Neurology"},{"key":"R4-4-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-018-0839-1","article-title":"An up to date review of pseudotumor cerebri syndrome","volume":"18","author":"Burkett","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R5-4-20240828","first-page":"508","article-title":"Intracranial venous hypertension and venous sinus stenting in the modern management of idiopathic intracranial hypertension","volume":"11","author":"Townsend","year":"2021","journal-title":"Life (Basel"},{"key":"R6-4-20240828","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/neurintsurg-2019-015251","article-title":"A descriptive study of venous sinus pressures and gradients in patients with idiopathic intracranial hypertension","volume":"12","author":"Fargen","year":"2020","journal-title":"J Neurointerv Surg"},{"key":"R7-4-20240828","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/neurintsurg-2019-015498","article-title":"Idiopathic intracranial hypertension is not idiopathic: Proposal for a new nomenclature and patient classification","volume":"12","author":"Fargen","year":"2020","journal-title":"J Neurointerv Surg"},{"key":"R8-4-20240828","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3171\/2011.10.JNS101410","article-title":"Dural sinus stent placement for idiopathic intracranial hypertension: Clinical article","volume":"116","author":"Kumpe","year":"2012","journal-title":"J Neurosurg"},{"key":"R9-4-20240828","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-0040-1709172","article-title":"Idiopathic intracranial hypertension: Contemporary management and endovascular techniques","volume":"37","author":"Case","year":"2020","journal-title":"Semin Intervent Radiol"},{"key":"R10-4-20240828","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/WNO.0000000000001000","article-title":"Idiopathic intracranial hypertension: Glymphedema of the brain","volume":"41","author":"Nicholson","year":"2021","journal-title":"J Neuroophthalmol"},{"key":"R11-4-20240828","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/jamaneurol.2019.1812","article-title":"Association between idiopathic intracranial hypertension and risk of cardiovascular diseases in women in the United Kingdom","volume":"76","author":"Adderley","year":"2019","journal-title":"JAMA Neurol"},{"key":"R12-4-20240828","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/head.13144","article-title":"The idiopathic intracranial hypertension treatment trial: A review of the outcomes","volume":"57","author":"Smith","year":"2017","journal-title":"Headache J Head Face Pain"},{"key":"R13-4-20240828","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaneurol.2014.133","article-title":"The idiopathic intracranial hypertension treatment trial clinical profile at baseline","volume":"71","author":"Wall","year":"2014","journal-title":"JAMA Neurol"},{"key":"R14-4-20240828","first-page":"55","article-title":"Whence pseudotumor cerebri?","volume":"5","author":"Smith","year":"1985","journal-title":"J Clin Neuroophthalmol"},{"key":"R15-4-20240828","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00000658-193710000-00002","article-title":"Intracranial pressure without brain tumor: Diagnosis and treatment","volume":"106","author":"Dandy","year":"1937","journal-title":"Ann Surg"},{"key":"R16-4-20240828","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/WNO.0000000000000767","article-title":"Utility of magnetic resonance imaging features for improving the diagnosis of idiopathic intracranial hypertension without papilledema","volume":"39","author":"Mallery","year":"2019","journal-title":"J Neuroophthalmol"},{"key":"R17-4-20240828","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1526-4610.2008.01324.x","article-title":"A comparison of idiopathic intracranial hypertension with and without papilledema","volume":"49","author":"Digre","year":"2009","journal-title":"Headache"},{"key":"R18-4-20240828","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/WNO.0000000000000448","article-title":"Obesity and weight loss in idiopathic intracranial hypertension: A narrative review","volume":"37","author":"Subramaniam","year":"2017","journal-title":"J Neuroophthalmol"},{"key":"R19-4-20240828","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jamaneurol.2021.0659","article-title":"Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: A randomized clinical trial","volume":"78","author":"Mollan","year":"2021","journal-title":"JAMA Neurol"},{"key":"R20-4-20240828","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/0333102418776455","article-title":"Topiramate is more effective than acetazolamide at lowering intracranial pressure","volume":"39","author":"Scotton","year":"2019","journal-title":"Cephalalgia"},{"key":"R21-4-20240828","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/WNO.0000000000000513","article-title":"Should acetazolamide be the first-line treatment for patients with idiopathic intracranial hypertension?","volume":"37","author":"Kaufman","year":"2017","journal-title":"J Neuroophthalmol"},{"key":"R22-4-20240828","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0404.2007.00905.x","article-title":"Treatment of idiopathic intracranial hypertension: Topiramate vs acetazolamide, an open-label study","volume":"116","author":"\u00c7elebisoy","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"R23-4-20240828","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12987-019-0155-4","article-title":"Preclinical update on regulation of intracranial pressure in relation to idiopathic intracranial hypertension","volume":"16","author":"Eftekhari","year":"2019","journal-title":"Fluids Barriers CNS"},{"key":"R25-4-20240828","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s10143-020-01288-1","article-title":"A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH)","volume":"44","author":"Kalyvas","year":"2021","journal-title":"Neurosurg Rev"},{"key":"R27-4-20240828","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/IOP.0000000000000326","article-title":"Optic nerve sheath fenestration: Current preferences in surgical approach and biopsy","volume":"31","author":"Sobel","year":"2015","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R29-4-20240828","first-page":"1365","article-title":"Optic nerve sheath decompression","volume":"106","author":"Keltner","year":"1988","journal-title":"How does it work? Has its time come? Arch Ophthalmol"},{"key":"R30-4-20240828","first-page":"25","article-title":"Bilateral retinal venous caliber decrease following unilateral optic nerve sheath decompression","volume":"26","author":"Lee","year":"1995","journal-title":"Ophthalmic Surg"},{"key":"R31-4-20240828","first-page":"471","article-title":"Efficacy and safety of optic nerve sheath fenestration in patients with raised intracranial pressure","volume":"33","author":"Yaqub","year":"2017","journal-title":"Pakistan J Med Sci"},{"key":"R32-4-20240828","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1177\/0333102411423305","article-title":"Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review","volume":"31","author":"Sinclair","year":"2011","journal-title":"Cephalalgia"},{"key":"R33-4-20240828","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.20142290","article-title":"A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules","volume":"212","author":"Aspelund","year":"2015","journal-title":"J Exp Med"},{"key":"R34-4-20240828","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/01.wnl.0000251312.19452.ec","article-title":"Fulminant idiopathic intracranial hypertension","volume":"68","author":"Thambisetty","year":"2007","journal-title":"Neurology"},{"key":"R36-4-20240828","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/jnnp.74.12.1662","article-title":"Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting","volume":"74","author":"Higgins","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R37-4-20240828","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.soard.2021.03.020","article-title":"Cost-effectiveness of bariatric surgery versus community weight management to treat obesity-related idiopathic intracranial hypertension: Evidence from a single-payer healthcare system","volume":"17","author":"Elliot","year":"2021","journal-title":"Surg Obes Relat Dis"},{"key":"R40-4-20240828","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/WNO.0000000000000777","article-title":"Headaches in idiopathic intracranial hypertension","volume":"39","author":"Friedman","year":"2019","journal-title":"J Neuro-ophthalmol"},{"key":"R41-4-20240828","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s10194-020-01182-7","article-title":"Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension","volume":"21","author":"Yiangou","year":"2020","journal-title":"J Headache Pain"},{"key":"R42-4-20240828","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s12028-013-9924-0","article-title":"The physiologic effects of indomethacin test on CPP and ICP in severe traumatic brain injury (sTBI)","volume":"20","author":"Godoy","year":"2014","journal-title":"Neurocrit Care"},{"key":"R43-4-20240828","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3389\/fneur.2019.01009","article-title":"The role of onabotulinum toxin type a in the management of chronic non-migraine headaches","volume":"10","author":"Jia","year":"2019","journal-title":"Front Neurol"},{"key":"R44-4-20240828","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/head.14125","article-title":"Headache attributed to idiopathic intracranial hypertension and persistent post-idiopathic intracranial hypertension headache: A narrative review","volume":"61","author":"Mollan","year":"2021","journal-title":"Headache"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_203_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:59:48Z","timestamp":1787756388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_203_22"}},"subtitle":["Diagnostic and Management Issues"],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":38,"journal-issue":{"issue":"Suppl 2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/aian.aian_203_22","relation":{},"ISSN":["0972-2327"],"issn-type":[{"value":"0972-2327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}